title: [Molecular characterization of carbapenemases in Pseudomonas aeruginosa infection. Clinical study in three oncological patients].
authors.forename: Tomás
authors.initials: T
authors.lastname: García-Lozano
authors.forename: Eduardo
authors.initials: E
authors.lastname: Aznar
authors.forename: Pablo
authors.initials: P
authors.lastname: Lorente
authors.forename: Concepción
authors.initials: C
authors.lastname: Gimeno
mesh_terms: D000368:Aged; D001426:Bacterial Proteins / Q000145:classification / Q000302:isolation & purification*; D001943:Breast Neoplasms / Q000150:complications; D015780:Carbapenems / Q000494:pharmacology; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000556:secondary; D002292:Carcinoma, Renal Cell / Q000150:complications; D003428:Cross Infection / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007680:Kidney Neoplasms / Q000150:complications; D007822:Laryngeal Neoplasms / Q000150:complications; D008297:Male; D009101:Multiple Myeloma / Q000150:complications; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification; D001749:Urinary Bladder Neoplasms / Q000150:complications; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000145:classification / Q000302:isolation & purification*
chemical_list: D001426:Bacterial Proteins; D015780:Carbapenems; D001618:beta-Lactamases; C063912:carbapenemase